LE SN#

Related by string. * Leer . LES . LEED . Les . les . leer . le . Leed . LEs . leed . LEER . Le : coach Les Miles . Char les . Environmental Design LEED . Le Mans Series . Petit Le Mans . fi le . LE . pour encourager les autres . daily Les Echos . LEED certified buildings . Les Echos . Da LES . Sa les . newspaper Les Echos . Le Gal . le gal . Le Pen . Les Grands Ballets Canadiens / SN# [001] . SN# [003] . SN# [002] . SN #D : PEG SN# . SN# writes * *

Related by context. Frequent words. (Click for all words.) 67 Phase III Clinical Trial 66 Pivotal Phase III 65 anticancer compound 65 PS# [001] 64 Drug Candidate 64 CCX# 64 Pivotal Phase 64 TOCOSOL Paclitaxel 64 Phase III Trial 64 MGCD# [001] 63 Completes Enrollment 63 Phase 2b study 63 TELCYTA 63 Onalta 63 Metastatic Melanoma 63 Phase 2a clinical 63 IND submission 63 Irinotecan 62 confirmatory Phase III 62 NGX# 62 elotuzumab 62 HspE7 62 Sym# 62 Phenoptin 62 HCV protease inhibitor 62 novel anticancer 62 Stedivaze 62 deforolimus 62 Carfilzomib 62 MOZOBIL 62 CoFactor 62 Azedra 62 Phase Ib clinical 62 Cloretazine R VNP#M 62 Icatibant 62 Voreloxin 62 registrational trial 62 ALN TTR# 62 Pivotal Trial 62 CYC# 62 Perifosine 62 Phase 2b clinical 62 CXA 62 pralatrexate 62 CA4P 62 Amrubicin 62 Phase IIa trial 62 Phase Ib 62 RGB # 62 Bone Graft 61 teduglutide 61 Allovectin 7 R 61 tanespimycin 61 DAVANAT 61 CR# vcMMAE 61 PREOS 61 Rebif ® 61 Virulizin R 61 Microspheres 61 injectable formulation 61 alvimopan 61 CRx 61 Atiprimod 61 6R BH4 61 ApoB SNALP 61 Bortezomib 61 Phase 1b clinical 61 Topical Interferon Alpha 2b 61 HGS ETR1 61 sodium Injection 61 epothilone 61 VQD 60 REPLAGAL 60 PXD# 60 SinuNase 60 ALN RSV# 60 Initiates Phase 60 ATL# [001] 60 EZN 60 orally bioavailable 60 ALN VSP 60 Belinostat 60 luteinizing hormone releasing 60 DR Cysteamine 60 KNS # 60 squalamine 60 ozarelix 60 confirmatory Phase 3 60 eltrombopag 60 Nexavar ® 60 Phase III clinical 59 humanized anti 59 AZX# 59 tezampanel 59 Chrysalin 59 OXi# 59 injection USP 59 Zerenex 59 custirsen 59 ONCONASE 59 BAY #-#

Back to home page